Neda K./LinkedIn
Apr 23, 2026, 16:55
Neda K.: When to Hold Antithrombotics and Use Bridging Therapy in Surgery
Neda K., Clinical Pharmacist, shared a post on LinkedIn:
”Perioperative Management of Antithrombotic: When to Hold Therapy
Perioperative management of antithrombotic therapy is all about balancing bleeding and thrombotic risks. The holding times for each agent are outlined in the image below.
Bridging Therapy: Who Really Needs It?
Indications for bridging when interrupting vitamin K antagonists:
Consider only in high thrombotic risk, such as:
- Mechanical heart valves
- Recent venous thromboembolism (VTE) (less than 3 months)
- Very high-risk atrial fibrillation
How to bridge?
- Discontinue warfarin 5 days before surgery.
- Start LMWH or UFH at therapeutic doses 3 days before surgery.
- Discontinue LMWH 24 hours or UFH 4 to 6 hours before surgery.”
Stay updated with Hemostasis Today.
-
Apr 23, 2026, 17:05Veronica Sanchez: The 2026 Guideline on the Management of Dyslipidemia
-
Apr 23, 2026, 16:57Hisam Siddiqi: Review of Interactive Cases by Blood Academy First Edition
-
Apr 23, 2026, 16:39Amanda Thijsen։ How Do People Feel After Donating Blood Or Plasma?
-
Apr 23, 2026, 16:36Simon Senanu: Microcytosis – Iron Deficiency vs Thalassemia
-
Apr 23, 2026, 16:26Ifeanyichukwu Ifechidere: The Framework for Mastering Coagulation Fundamentals
-
Apr 23, 2026, 16:12Fayad Al-Haimus։ HI-PEITHO Shows Reduced PE Complications Without Increased Bleeding
-
Apr 23, 2026, 16:04Hamid Yousaif Qureshi: Japanese Scientists Develop Artificial Blood
-
Apr 23, 2026, 15:5810 Treating Fairly Research Awards – ASH
-
Apr 23, 2026, 15:51Abeer Alanazi: Secondary Stroke Prevention in Atrial Fibrillation